Skip to main content
Erschienen in: World Journal of Surgery 3/2022

09.01.2022 | Original Scientific Report

Survival Prediction Capabilities of Preoperative Inflammatory and Nutritional Status in Esophageal Squamous Cell Carcinoma Patients

verfasst von: Kotaro Sugawara, Koichi Yagi, Yasuhiro Okumura, Susumu Aikou, Hiroharu Yamashita, Yasuyuki Seto

Erschienen in: World Journal of Surgery | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Studies have revealed the impacts of various inflammatory and nutritional markers in patients with esophageal squamous cell carcinoma (ESCC). We evaluated the prognostic values of multiple inflammation- or nutrition-based markers, either alone or in combination with pStage, in ESCC patients.

Methods

In total, 360 patients undergoing upfront surgery for ESCC were retrospectively reviewed. The prognostic capabilities of 7 inflammatory and 3 nutritional parameters were investigated. Furthermore, we devised new staging systems by adding these markers to pStage and examined the prognostic abilities of our new approach. Time-dependent receiver operating characteristic curves and the areas under the curve (AUCs) were estimated to compare prognostic capabilities among the parameters.

Results

The AUCs for predicting overall survival (OS) of the prognostic nutritional index (PNI), CRP to albumin ration (CAR), lymphocyte to CRP ratio (LCR) and the Naples prognostic score (NPS) were similar to that of pStage. Notably, CAR and LCR showed high predictive capabilities for OS (AUCs; 0.627 and 0.634 for 3-year OS, respectively). New staging systems combining inflammatory or nutritional markers with pStage provided higher AUCs for predicting OS than pStage alone. In particular, NPpStage (NPS and pStage) (P = 0.03), PNpStage (PNI and pStage) (P = 0.03) and LCpStage (LCR and pStage) (P = 0.05) showed significantly higher accuracy for predicting OS than pStage alone.

Conclusions

Various inflammatory or nutritional markers, especially those derived from CRP, are useful for predicting survival outcomes of ESCC patients. The predictive capabilities of these indices were augmented when used in combination with pStage.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Abnet CC, Arnold M, Wei WQ (2018) Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154:360–373PubMed Abnet CC, Arnold M, Wei WQ (2018) Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154:360–373PubMed
2.
Zurück zum Zitat Lagergren J, Smyth E, Cunningham D et al (2017) Oesophageal cancer. Lancet 390:2383–2396PubMed Lagergren J, Smyth E, Cunningham D et al (2017) Oesophageal cancer. Lancet 390:2383–2396PubMed
3.
Zurück zum Zitat Wang VE, Grandis JR, Ko AH (2016) New strategies in esophageal carcinoma: translational insights from signaling pathways and immune checkpoints. Clin Cancer Res 22:4283–4290PubMed Wang VE, Grandis JR, Ko AH (2016) New strategies in esophageal carcinoma: translational insights from signaling pathways and immune checkpoints. Clin Cancer Res 22:4283–4290PubMed
4.
Zurück zum Zitat Rice TW, Blackstone EH, Rusch VW (2010) 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 17:1721–1724PubMed Rice TW, Blackstone EH, Rusch VW (2010) 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 17:1721–1724PubMed
5.
Zurück zum Zitat Yodying H, Matsuda A, Miyashita M et al (2016) Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol 23:646–654PubMed Yodying H, Matsuda A, Miyashita M et al (2016) Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol 23:646–654PubMed
6.
Zurück zum Zitat Xie X, Luo KJ, Hu Y et al (2016) Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer. Dis Esophagus 29:79–85PubMed Xie X, Luo KJ, Hu Y et al (2016) Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer. Dis Esophagus 29:79–85PubMed
7.
Zurück zum Zitat Ishibashi Y, Tsujimoto H, Hiraki S et al (2018) Prognostic value of preoperative systemic immunoinflammatory measures in patients with esophageal cancer. Ann Surg Oncol 25:3288–3299PubMed Ishibashi Y, Tsujimoto H, Hiraki S et al (2018) Prognostic value of preoperative systemic immunoinflammatory measures in patients with esophageal cancer. Ann Surg Oncol 25:3288–3299PubMed
8.
Zurück zum Zitat Hikage M, Taniyama Y, Sakurai T et al (2019) The influence of the perioperative nutritional status on the survival outcomes for esophageal cancer patients with neoadjuvant chemotherapy. Ann Surg Oncol 26:4744–4753PubMed Hikage M, Taniyama Y, Sakurai T et al (2019) The influence of the perioperative nutritional status on the survival outcomes for esophageal cancer patients with neoadjuvant chemotherapy. Ann Surg Oncol 26:4744–4753PubMed
9.
Zurück zum Zitat Galizia G, Lieto E, Auricchio A et al (2017) Naples prognostic score, based on nutritional and inflammatory status, is an independent predictor of long-term outcome in patients undergoing surgery for colorectal cancer. Dis Colon Rectum 60:1273–1284PubMed Galizia G, Lieto E, Auricchio A et al (2017) Naples prognostic score, based on nutritional and inflammatory status, is an independent predictor of long-term outcome in patients undergoing surgery for colorectal cancer. Dis Colon Rectum 60:1273–1284PubMed
10.
Zurück zum Zitat Okugawa Y, Toiyama Y, Yamamoto A et al (2020) Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg 272:342–351PubMed Okugawa Y, Toiyama Y, Yamamoto A et al (2020) Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg 272:342–351PubMed
11.
Zurück zum Zitat Kano K, Yamada T, Yamamoto K et al (2021) The impact of pretherapeutic Naples prognostic score on survival in patients with locally advanced esophageal cancer. Ann Surg Oncol 28:4540–4541PubMed Kano K, Yamada T, Yamamoto K et al (2021) The impact of pretherapeutic Naples prognostic score on survival in patients with locally advanced esophageal cancer. Ann Surg Oncol 28:4540–4541PubMed
12.
Zurück zum Zitat Yamamoto A, Toiyama Y, Okugawa Y et al (2020) Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients. Surg Today 51:745–755PubMed Yamamoto A, Toiyama Y, Okugawa Y et al (2020) Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients. Surg Today 51:745–755PubMed
13.
Zurück zum Zitat Xu XL, Yu HQ, Hu W et al (2015) A novel inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One 10:e0138657PubMedPubMedCentral Xu XL, Yu HQ, Hu W et al (2015) A novel inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One 10:e0138657PubMedPubMedCentral
14.
Zurück zum Zitat Zhang H, Shang X, Ren P et al (2019) The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. J Cell Physiol 234:1794–1802PubMed Zhang H, Shang X, Ren P et al (2019) The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. J Cell Physiol 234:1794–1802PubMed
15.
Zurück zum Zitat Lin JX, Lin LZ, Tang YH et al (2020) Which nutritional scoring system is more suitable for evaluating the short- or long-term prognosis of patients with gastric cancer who underwent radical gastrectomy? J Gastrointest Surg 24:1969–1977PubMed Lin JX, Lin LZ, Tang YH et al (2020) Which nutritional scoring system is more suitable for evaluating the short- or long-term prognosis of patients with gastric cancer who underwent radical gastrectomy? J Gastrointest Surg 24:1969–1977PubMed
16.
Zurück zum Zitat Liu X, Wu Z, Lin E et al (2019) Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II–III gastric cancer patients with adjuvant chemotherapy. Clin Nutr 38:1853–1860PubMed Liu X, Wu Z, Lin E et al (2019) Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II–III gastric cancer patients with adjuvant chemotherapy. Clin Nutr 38:1853–1860PubMed
17.
Zurück zum Zitat Jomrich G, Paireder M, Kristo I et al (2019) High systemic immune-inflammation index is an adverse prognostic factor for patients with gastroesophageal adenocarcinoma. Ann Surg 273:532–541 Jomrich G, Paireder M, Kristo I et al (2019) High systemic immune-inflammation index is an adverse prognostic factor for patients with gastroesophageal adenocarcinoma. Ann Surg 273:532–541
18.
Zurück zum Zitat Sugawara K, Yoshimura S, Yagi K, et al (2019) Long-term health-related quality of life following robot-assisted radical transmediastinal esophagectomy. Surg Endosc Sugawara K, Yoshimura S, Yagi K, et al (2019) Long-term health-related quality of life following robot-assisted radical transmediastinal esophagectomy. Surg Endosc
19.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMed Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMed
20.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann Surg 240:205–213PubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann Surg 240:205–213PubMedPubMedCentral
21.
Zurück zum Zitat Kuwano H, Nishimura Y, Oyama T et al (2015) Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus: official journal of the Japan Esophageal Society 12:1–30 Kuwano H, Nishimura Y, Oyama T et al (2015) Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus: official journal of the Japan Esophageal Society 12:1–30
22.
Zurück zum Zitat Kuroda D, Sawayama H, Kurashige J et al (2018) Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer 21:204–212PubMed Kuroda D, Sawayama H, Kurashige J et al (2018) Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer 21:204–212PubMed
23.
Zurück zum Zitat Blanche P, Dartigues JF, Jacqmin-Gadda H (2013) Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med 32:5381–5397PubMed Blanche P, Dartigues JF, Jacqmin-Gadda H (2013) Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med 32:5381–5397PubMed
24.
Zurück zum Zitat Pencina MJ, D’Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23:2109–2123PubMed Pencina MJ, D’Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23:2109–2123PubMed
25.
Zurück zum Zitat Kalinkovich A, Livshits G (2017) Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev 35:200–221PubMed Kalinkovich A, Livshits G (2017) Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev 35:200–221PubMed
26.
Zurück zum Zitat Sugawara K, Yagi K, Uemura Y et al (2020) Associations of systemic inflammation and sarcopenia with survival of esophageal carcinoma patients. Ann Thorac Surg 110:374–382PubMed Sugawara K, Yagi K, Uemura Y et al (2020) Associations of systemic inflammation and sarcopenia with survival of esophageal carcinoma patients. Ann Thorac Surg 110:374–382PubMed
27.
Zurück zum Zitat Diakos CI, Charles KA, McMillan DC et al (2014) Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15:e493-503PubMed Diakos CI, Charles KA, McMillan DC et al (2014) Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15:e493-503PubMed
28.
Zurück zum Zitat Kudou K, Nakashima Y, Haruta Y et al (2021) Comparison of inflammation-based prognostic scores associated with the prognostic impact of adenocarcinoma of esophagogastric junction and upper gastric cancer. Ann Surg Oncol 28:2059–2067PubMed Kudou K, Nakashima Y, Haruta Y et al (2021) Comparison of inflammation-based prognostic scores associated with the prognostic impact of adenocarcinoma of esophagogastric junction and upper gastric cancer. Ann Surg Oncol 28:2059–2067PubMed
29.
Zurück zum Zitat Wen J, Bedford M, Begum R et al (2018) The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma. J Surg Oncol 117:1697–1707PubMed Wen J, Bedford M, Begum R et al (2018) The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma. J Surg Oncol 117:1697–1707PubMed
30.
Zurück zum Zitat Nakagawa N, Yamada S, Sonohara F et al (2020) Clinical implications of Naples prognostic score in patients with resected pancreatic cancer. Ann Surg Oncol 27:887–895PubMed Nakagawa N, Yamada S, Sonohara F et al (2020) Clinical implications of Naples prognostic score in patients with resected pancreatic cancer. Ann Surg Oncol 27:887–895PubMed
31.
Zurück zum Zitat Galizia G, Auricchio A, de Vita F et al (2019) Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. Ann Ital Chir 90:404–416PubMed Galizia G, Auricchio A, de Vita F et al (2019) Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. Ann Ital Chir 90:404–416PubMed
32.
Zurück zum Zitat Jagadesham VP, Lagarde SM, Immanuel A et al (2017) Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. Br J Surg 104:401–407PubMed Jagadesham VP, Lagarde SM, Immanuel A et al (2017) Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. Br J Surg 104:401–407PubMed
33.
Zurück zum Zitat Xue W, Xu X, Tan Y et al (2020) Evaluation and validation of the prognostic value of nutrition and immunity parameters in gastric cancer after R0 resection. Medicine (Baltimore) 99:e19270 Xue W, Xu X, Tan Y et al (2020) Evaluation and validation of the prognostic value of nutrition and immunity parameters in gastric cancer after R0 resection. Medicine (Baltimore) 99:e19270
34.
Zurück zum Zitat Sugawara K, Yamashita H, Urabe M et al (2020) Poor nutritional status and sarcopenia influences survival outcomes in gastric carcinoma patients undergoing radical surgery. Eur J Surg Oncol 46:1963–1970PubMed Sugawara K, Yamashita H, Urabe M et al (2020) Poor nutritional status and sarcopenia influences survival outcomes in gastric carcinoma patients undergoing radical surgery. Eur J Surg Oncol 46:1963–1970PubMed
35.
Zurück zum Zitat Lin JX, Huang YQ, Xie JW et al (2019) Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy. Eur J Surg Oncol 45:2465–2472PubMed Lin JX, Huang YQ, Xie JW et al (2019) Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy. Eur J Surg Oncol 45:2465–2472PubMed
37.
Zurück zum Zitat Otowa Y, Nakamura T, Yamamoto M et al (2017) C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer. Dis Esophagus 30:1–5PubMed Otowa Y, Nakamura T, Yamamoto M et al (2017) C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer. Dis Esophagus 30:1–5PubMed
38.
Zurück zum Zitat Li Z, Li S, Ying X et al (2020) The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy. Gastric Cancer 23:540–549PubMedPubMedCentral Li Z, Li S, Ying X et al (2020) The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy. Gastric Cancer 23:540–549PubMedPubMedCentral
39.
Zurück zum Zitat Buffart LM, Kalter J, Sweegers MG et al (2017) Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev 52:91–104PubMed Buffart LM, Kalter J, Sweegers MG et al (2017) Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev 52:91–104PubMed
40.
Zurück zum Zitat Roxburgh CS, McMillan DC (2014) Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer 110:1409–1412PubMedPubMedCentral Roxburgh CS, McMillan DC (2014) Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer 110:1409–1412PubMedPubMedCentral
41.
Zurück zum Zitat Kong SH, Lee HJ, Na JR et al (2018) Effect of perioperative oral nutritional supplementation in malnourished patients who undergo gastrectomy: a prospective randomized trial. Surgery 164:1263–1270PubMed Kong SH, Lee HJ, Na JR et al (2018) Effect of perioperative oral nutritional supplementation in malnourished patients who undergo gastrectomy: a prospective randomized trial. Surgery 164:1263–1270PubMed
42.
Zurück zum Zitat Yamamoto K, Nagatsuma Y, Fukuda Y et al (2017) Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer. Gastric Cancer 20:913–918PubMed Yamamoto K, Nagatsuma Y, Fukuda Y et al (2017) Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer. Gastric Cancer 20:913–918PubMed
43.
Zurück zum Zitat Baker M, Halliday V, Williams RN et al (2016) A systematic review of the nutritional consequences of esophagectomy. Clin Nutr 35:987–994PubMed Baker M, Halliday V, Williams RN et al (2016) A systematic review of the nutritional consequences of esophagectomy. Clin Nutr 35:987–994PubMed
44.
Zurück zum Zitat Mudge LA, Watson DI, Smithers BM et al (2018) Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancer. Br J Surg 105:1262–1272PubMed Mudge LA, Watson DI, Smithers BM et al (2018) Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancer. Br J Surg 105:1262–1272PubMed
45.
Zurück zum Zitat Tachimori Y, Ozawa S, Numasaki H et al (2017) Comprehensive registry of esophageal cancer in Japan, 2010. Esophagus 14:189–214PubMedPubMedCentral Tachimori Y, Ozawa S, Numasaki H et al (2017) Comprehensive registry of esophageal cancer in Japan, 2010. Esophagus 14:189–214PubMedPubMedCentral
Metadaten
Titel
Survival Prediction Capabilities of Preoperative Inflammatory and Nutritional Status in Esophageal Squamous Cell Carcinoma Patients
verfasst von
Kotaro Sugawara
Koichi Yagi
Yasuhiro Okumura
Susumu Aikou
Hiroharu Yamashita
Yasuyuki Seto
Publikationsdatum
09.01.2022
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 3/2022
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-021-06398-5

Weitere Artikel der Ausgabe 3/2022

World Journal of Surgery 3/2022 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Traumatologische Notfälle Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.